MicroRNA-Based Drugs for Brain Tumors
- PMID: 29506672
- DOI: 10.1016/j.trecan.2017.12.008
MicroRNA-Based Drugs for Brain Tumors
Abstract
MicroRNAs (miRNAs) are key regulatory elements encoded by the genome. A single miRNA can downregulate the expression of multiple genes involved in diverse functions. Because cancer is a disease with multiple gene aberrations, developing novel approaches to identify and modulate miRNA pathways may result in a breakthrough for cancer treatment. With a special focus on glioblastoma (GBM), this review provides an up-to-date summary of miRNA biogenesis, the role of miRNA in cancer resistance, and essential tools for modulating miRNA expression, as well as of clinically promising RNAi delivery systems and how they can be adapted for therapy.
Keywords: RNAi; argonaute; brain targeting; cancer resistance; drug delivery; exosomes; glioblastoma; nanoparticles.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
